A complete application in a minute — tailored resume and cover letter, ready to send.
Zealand Pharma U.S., Inc. seeks a Manager/Senior Manager to build the US compliance program ahead of first commercial launch.
The role is remote in the United States with some travel, reporting to the Head of US Compliance, and will shape policies, controls, and training for commercial, medical, market access, and patient services teams. You will design frameworks for ongoing compliance, oversee Open Payments and registration requirements, and collaborate with Finance to ensure proper
Manager / Senior Manager, US Compliance Does it excite you to build a US compliance program from the ground up ahead of first commercial launch, and do you have experience taking a pharmaceutical or biotech organization through US launch readiness? If this sounds like you, and you are ready to take on a broad area of responsibilities, then you could be our new colleague.
Your new position As Manager / Senior Manager, US Compliance, you will join a growing US organization ahead of commercialization and help lay the compliance foundation on which the future US business will operate. Reporting to the Head of US Compliance, you will help design policies, controls and training that do not yet exist, and prepare the frameworks that commercial, medical, market access and patient services colleagues will rely on once activities go live. This is a builder’s role rather than a maintenance one, offering breadth and visibility that is rare in larger, more established organizations. The position can be performed remotely from the United States, with some travel expected.
Your profile You are pragmatic, curious and energized by building rather than inheriting. You are comfortable in an environment where the answer is often “we haven’t decided yet,” and you enjoy being close to the business, offering clear risk-based guidance rather than binary answers. Strong judgment, discretion and the ability to build trust across functions matter more here than depth in any single sub-discipline. You work well independently in a remote setting and collaborate easily across US and Danish colleagues.
You will join the US Compliance function within Legal, reporting directly to the Head of US Compliance. The team supports Zealand Pharma’s growing US organization, based in Cambridge, Massachusetts, and works closely with global colleagues at headquarters in Copenhagen, Denmark.
We have a unique culture, characterized by excellent teamwork and strong engagement across the organization. And we want you to help us strengthen this culture. Making bonds is at the core of everything we do. From discovering and developing the best new peptide drugs for patients, to engaging with our partners or connecting with each other. We bond through curiosity and playfulness as a team, allowing ourselves to challenge common thinking and drive future innovation. Join us and let’s bond and be bold.
We are committed to an inclusive recruitment process and welcome applications from all job applicants.
Zealand Pharma A/S (Nasdaq: ZEAL) is a biotechnology company focused on advancing medicines for obesity and metabolic health. Combining more than 25 years of peptide R&D expertise with a proprietary data platform that leverages advanced data-driven and AI/ML approaches, Zealand Pharma aims to lead a new era in obesity and metabolic health.
To date, more than ten Zealand Pharma-invented drug candidates have entered clinical development, of which two products have reached the market and three candidates are in late-stage development.
The Company has collaborations with global pharmaceutical and biotechnology partners for research, development, and commercialization. Founded in 1998, Zealand Pharma is headquartered in Copenhagen, Denmark, with a U.S. presence in Cambridge, Massachusetts. Learn more at www.zealandpharma.com.
Since our founding in 1998, Zealand Pharma has built a core expertise in the discovery, design, and development of therapeutic peptides. This expertise has led to an R&D pipeline of innovative investigational candidates designed to address a broad range of disease areas.
We have four therapeutic focus areas: obesity, rare diseases, chronic inflammation, and type 1 diabetes.
In obesity, our peptide capabilities place us in a unique position to address a vast global health challenge and positively impact hundreds of millions of lives.
Within rare diseases, we have a long-standing commitment to deliver new treatments to patients living with congenital hyperinsulinism and short bowel syndrome.
For chronic inflammatory diseases, we are progressing peptide programs focused on high-profile targets shown to be difficult to address with small molecules and antibodies.
For type 1 diabetes, we aspire to change the management of this disease.
Our strategy is to pursue global co-development and commercialization partnerships that complement and extend our capabilities across the value chain to deliver new peptide therapies to people who need them.